Crossmark

Caregiver burden of IBD patients in Asian Emerging Nations is significant and necessitates attention and resource allocation

Published Online: 2024-08-01

Published Print: 2024-12

Authors

Taft, Tiffany H. https://orcid.org/0000-0002-4670-2441
Aswani-Omprakash, Tina
License Information

Text and Data Mining valid from 2024-08-01

Version of Record valid from 2024-08-01
More Information

Article History

First Online: 1 August 2024

Declarations

:

: TT has ownership in Oak Park Behavioral Medicine LLC and serves on the scientific advisory board for Ayble Health. TAO is employed by Sommer Consulting d/b/a Linguis-Tech, Inc. TAO has served in an advisory capacity for Ardelyx, Johnson & Johnson, Genentech-Roche, Takeda, Pfizer, Tillotts AG, Parexel, and Merck. TAO has done consulting work for AbbVie, Ardelyx, Johnson & Johnson, Genentech-Roche, Pfizer, Boehringer Ingelheim, Hollister, Inc., Parexel, Walgreens, Eli Lilly and Convatec. TAO has served on the speaker’s bureau for AbbVie, Iterative Health, Johnson & Johnson, Genentech-Roche, Takeda, Pfizer, Hollister, Inc., Boehringer Ingelheim, and Parexel.

: The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer/publishers are responsible for the results/findings and content of this article.

Free to read: This content has been made available to all.

Document is current